Tsima Abou Kors

Biochemistry, Genetics and Molecular Biology · Life Sciences

4h-index61citations45works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related molecular mechanisms research(20), Head and Neck Cancer Studies(16), Cancer Immunotherapy and Biomarkers(4), RNA modifications and cancer(4), Immunotherapy and Immune Responses(3)

Publications45 total

The role of plasma-derived small extracellular vesicles in pre-metastatic niche formation through modulation of macrophages in head and neck squamous cell carcinoma
British Journal of Cancer·2025· 3 citedOpen Access
5-Aza-2′-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cells
Neoplasia·2024· 5 citedOpen Access
915P Longer OS and RFS for CD3high/PD-L1+ head and neck squamous cell carcinoma (HNSCC) patients
Annals of Oncology·2024· 1 citedOpen Access
Multi-omics analysis of overexpressed tumor-associated proteins: gene expression, immunopeptide presentation, and antibody response in oropharyngeal squamous cell carcinoma, with a focus on cancer-testis antigens
Frontiers in Immunology·2024· 4 citedOpen Access
Validation of HLA presented tumor-exclusive peptides in an independent cohort of head and neck squamous cell carcinoma.
Journal of Clinical Oncology·2024
Die Kombination aus dichtem T-Zell-Infiltrat und PD-L1 Expression identifiziert Kopf-Hals-Tumor Patienten mit besonders guter Prognose
Laryngo-Rhino-Otologie·2024
Combining CD3 density and PD-L1 expression into one prognostic factor identifies patients with an exceptional prognosis
Laryngo-Rhino-Otologie·2024
FIGURE 5 from <i>INHBA</i> is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression
2024Open Access
FIGURE 7 from <i>INHBA</i> is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression
2024Open Access
FIGURE 3 from <i>INHBA</i> is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression
2024Open Access
FIGURE 4 from <i>INHBA</i> is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression
2024Open Access
FIGURE 5 from <i>INHBA</i> is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression
2024Open Access
FIGURE 1 from <i>INHBA</i> is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression
2024Open Access
Data from <i>INHBA</i> is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression
2024Open Access
FIGURE 2 from <i>INHBA</i> is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression
2024Open Access
Supplementary Table 1 from <i>INHBA</i> is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression
2024Open Access
FIGURE 6 from <i>INHBA</i> is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression
2024Open Access
Supplementary Figure 1 from <i>INHBA</i> is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression
2024Open Access
FIGURE 4 from <i>INHBA</i> is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression
2024Open Access
FIGURE 3 from <i>INHBA</i> is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression
2024Open Access
page 1 of 3Next →

Frequent Co-authors

Simon Laban(43), Thomas K. Hoffmann(43), Cornelia Brunner(42), Adrian von Witzleben(41), Jasmin Ezić(38), Marie‐Nicole Theodoraki(37), Annika Betzler(37), Jens Greve(37), Linda Hofmann(35), Patrick J. Schuler(35), Johann M. Kraus(35), Hans A. Kestler(35), Diana Huber(34), Christian H. Ottensmeier(34), Julian Benckendorff(33), Kathrina Payer(32), Martin Bens(32), Randa Kalaajieh(32), Jens Truong(31), Jaya Thomas(31)